The expression of STAT3 target genes, Survivin, Bcl-2 and Bcl-xl, were decreased in SSMC 7721, Huh7, HEPG2 and Hep3B liver cancer cells after treatment with LY5 as examined by Western Blot (Figure 2A–2D). Here, BCL2L1 is linked to liver cancer.